Vaccines

29 Nov 2010 Sanofi Pasteur Starts a Phase II Vaccine Trial for Primary Prevention of Clostridium Difficile
25 Nov 2010 VIVALIS : ACHIEVES A SIGNIFICANT MILESTONE WITH THE ACCEPTANCE OF AN INVESTIGATIONAL NEW DRUG FILING (IND) FOR A CANDIDATE INFLUENZA VACCINE USING EB66 CELL-BASED TECHNOLOGY
24 Nov 2010 Advaxis India Cervix Cancer Trial Begins Dosing
22 Nov 2010 Celldex Therapeutics Reports Positive Results from Rindopepimut Phase 2 Brain Cancer Study at SNO 2010
18 Nov 2010 Further Analysis of Vacc-4x Phase IIb Study Shows a Statistically Significant Reduction in Viral Load Over Placebo -- Previous Decision to Put Vacc-4x on Hold Has Been Reversed
18 Nov 2010 FDA Advisory Committee Supports Approval of Merck & Co.'s GARDASIL(R) for Prevention of Anal Cancer and AIN in both Men and Women
17 Nov 2010 Inovio Pharmaceuticals’ HIV DNA Vaccine Achieves Strong T-Cell Immune Responses in Phase I Human Trial
17 Nov 2010 Immunovaccine Inc. Announces Phase I/II Clinical Plan for DPX-Survivac to Target Ovarian Cancer
12 Nov 2010 London Genetics and Astrimmune to Collaborate on Cancer Vaccine
11 Nov 2010 Pevion's Breakthrough Candida Vaccine Demonstrates Safety and Immunogenicity in Phase I Clinical Study
10 Nov 2010 Diamyd Completes Screening for US Phase III Study
09 Nov 2010 Nabi Biopharmaceuticals Completes Enrollment of Second NicVAX Phase III Clinical Trial
08 Nov 2010 Advaxis Enters into Collaboration with the University of British Columbia
05 Nov 2010 New clinical study started with the nicotine vaccine NIC002
04 Nov 2010 Sanofi Pasteur's Dengue Vaccine in Final Stage of Clinical Development
04 Nov 2010 Novel Recombinant Chikungunya Virus Vaccine Shown to be Safe and Effective in Multiple Animal Models
02 Nov 2010 Soligenix Announces Completion of Enrollment and Preliminary Safety Results of a Phase 1B Clinical Trial for RiVax
01 Nov 2010 Medicago Receives Regulatory Approval and Commences Phase II Clinical Testing of its Avian Influenza Vaccine
01 Nov 2010 Phase 2b Study Demonstrates GlobeImmune's GI-5005 HCV Therapeutic Vaccine Increases Sustained Virologic Response by 12 Percent in Patients Who Previously Failed Therapy With Standard of Care
28 Oct 2010 Crucell N.V. (CRXL) Halts Vaccine Shipments to Investigate Plant
28 Oct 2010 GlobeImmune Expands GI-5005-02 Phase 2b Trial to Include Additional Treatment Naive IL28B T/T Subjects With Chronic Genotype 1 HCV
28 Oct 2010 ImmuneRegen BioSciences(R) Reports Positive Results in Cancer Vaccine Studies in Radboud University Collaboration
25 Oct 2010 Phase III data show that Novartis meningococcal vaccine Menveo(R) demonstrated robust immunogenicity in infants
25 Oct 2010 Intercell Reports Positive Results From Its Phase II Pseudomonas Aeruginosa Investigational Vaccine Study for Certain Hospital-Acquired Infections
25 Oct 2010 Sanofi Pasteur Presents Phase III Data on Intradermal Microinjection of Influenza Vaccine

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top